Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma

Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma

BackgroundThe use of immunotherapy for the treatment of esophageal squamous cell carcinoma (ESCC) is gradually increasing. In this retrospective study, we evaluated the efficacy and explored potential factors of prognosis in multi-line sintilimab for unresectable advanced ESCC.MethodsAll pathologica...

Full description

Bibliographic Details
Main Authors: Shuhui Xu, Xianxing Xu, Hui Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
pre-immunotherapy
immunotherapy
sintilimab
esophageal squamous cell carcinoma
efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.960339/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.960339/full

Similar Items